Literature DB >> 1149946

The effect of phenformin on amino acid-induced insulin secretion in diabetics.

A Czyzyk, J Lawecki, H Rogala, B Malczewski, H Kowalski.   

Abstract

Twenty-one patients with mild maturity-onset diabetes were given introduodenal infusions of an amino acid mixture (0.5 g amino acids per kg body weight). In 9 other patients L-arginine was infused intravenously in a constant dose of 25 g. Alpha-amino nitrogen, blood glucose and plasma insulin levels were assayed under control conditions and after three days of treatment with phenformin, 150 mg daily, plus the same 150 mg dose 60 min before the second loading. Intraduodenal infusion of the amino acid mixture provoked a greater increase in plasma insulin than intravenous infusion of L-arginine, this increase being significantly inhibited by phenformin only in the first case. Since no evident influence of phenformin on the intestinal absorption of amino acids could be demonstrated, this effect may be explained by a local action on the intestinal wall exposed to high concentrations of the drug, resulting in the inhibition of the insulin secretion stimulating activity of the gut.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1149946     DOI: 10.1007/bf00429835

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Effect of biguanides on intestinal absorption of glucose.

Authors:  A Czyzyk; J Tawecki; J Sadowski; I Ponikowska; Z Szczepanik
Journal:  Diabetes       Date:  1968-08       Impact factor: 9.461

2.  Tissue distribution and excretion of phenformin in normal and diabetic animals.

Authors:  H Hall; G Ramachander; J M Glassman
Journal:  Ann N Y Acad Sci       Date:  1968-03-26       Impact factor: 5.691

3.  Effect of phenformin on water and glucose transport across isolated human ileum.

Authors:  D L Wingate; G D Hadley
Journal:  Diabetes       Date:  1973-03       Impact factor: 9.461

4.  Analysis of the inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport.

Authors:  W F Caspary; W Creutzfeldt
Journal:  Diabetologia       Date:  1971-10       Impact factor: 10.122

5.  Distribution of n-butylbiguanide-14C hydrochloride in mouse tissues.

Authors:  Y J Yoh
Journal:  Jpn J Pharmacol       Date:  1967-09

6.  [Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides].

Authors:  P Berchtold; P Bolli; U Arbenz; G Keiser
Journal:  Diabetologia       Date:  1969-12       Impact factor: 10.122

7.  Studies on the site and mechanism of action of phenformin. I. Evidence for significant "nonperipheral" effects of phenformin on glucose metabolism in normal subjects.

Authors:  S L Hollobaugh; M B Rao; F A Kruger
Journal:  Diabetes       Date:  1970-01       Impact factor: 9.461

8.  Effects of phenformin on insulin reserve and release.

Authors:  B R Boshell; R F Roddam; G L McAdams
Journal:  Ann N Y Acad Sci       Date:  1968-03-26       Impact factor: 5.691

9.  Effects of guanidine derivatives on mitochondrial function. 3. The mechanism of phenethylbiguanide accumulation and its relationship to in vitro respiratory inhibition.

Authors:  F Davidoff
Journal:  J Biol Chem       Date:  1971-06-25       Impact factor: 5.157

10.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15
View more
  1 in total

1.  The effect of phenformin upon the plasma pancreatic and gut glucagon-like immunoreactivity in diabetics.

Authors:  A Czyzyk; L G Heding; B Malczewski; E Miedzinska
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.